Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 15Bofanglutide literatureOne health (Amsterdam, Netherlands) · Review2026

One Health implementation for rabies elimination in India by 2030: Progress, governance, challenges, and policy alignment.

Achieving rabies elimination in India by 2030 requires addressing governance and surveillance gaps and improving access to prophylaxis.

Read at One health (Amsterdam, Netherlands)Add to compare

Where it sits

this study against the rest of the bofanglutide corpus
5
Preclinical
4
Observational
0
Open-label
2
Randomised
4
Reviews · this one

Summary and findings

The commentary discusses India's progress and challenges in eliminating dog-mediated human rabies by 2030 under the National Action Plan for Rabies Elimination. It highlights gaps in implementation, such as fragmented governance and inadequate canine vaccination coverage. The paper suggests operational One Health systems and improved access to prophylaxis are needed for success.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as One health (Amsterdam, Netherlands) supplied them

India has committed to eliminating dog-mediated human rabies by 2030 through the National Action Plan for Rabies Elimination (NAPRE), aligned with the global "Zero by 30" target within a One Health framework. Yet nationally representative 2022-23 data indicate that substantial dog-bite exposure and preventable rabies deaths persist despite effective preventive interventions. This commentary argues that India's slow progress reflects implementation gaps, including fragmented governance, weak integrated surveillance, inadequate canine vaccination coverage, inequitable access to timely post-exposure prophylaxis (PEP), and limited multisectoral accountability. Achieving elimination requires operational One Health systems with integrated surveillance, sustained mass dog vaccination, universal intradermal PEP access, and targeted pre-exposure prophylaxis (PrEP) in low PEP access high-risk settings.

Background

Rabies is a fatal viral disease that remains a public health concern in India, primarily transmitted through dog bites. The National Action Plan for Rabies Elimination aims to eradicate dog-mediated human rabies by 2030, in line with global targets. This study is significant as it evaluates the progress and challenges in implementing this plan within a One Health framework, which integrates human, animal, and environmental health strategies.

Methods

Not reported in abstract.

Results

The commentary identifies several barriers to rabies elimination in India, including fragmented governance, weak integrated surveillance systems, and inadequate canine vaccination coverage. It also notes the inequitable access to post-exposure prophylaxis and limited multisectoral accountability as significant challenges. The paper emphasizes the need for operational One Health systems and sustained mass dog vaccination to achieve the elimination goal.

Interpretation

The findings suggest that while preventive interventions for rabies are effective, their implementation is hindered by systemic issues such as governance and resource allocation. Compared to prior literature, this commentary highlights the need for a more integrated and accountable approach. The lack of new empirical data limits the ability to assess the clinical significance of proposed solutions.

Key findings

  • Substantial dog-bite exposure persists in India as of 2022-23.
  • Preventable rabies deaths continue despite effective interventions.
  • Inadequate canine vaccination coverage is a significant barrier.
  • Equitable access to post-exposure prophylaxis remains limited.
  • Fragmented governance hinders rabies elimination efforts.

Limitations

  • Commentary, no new empirical data
  • Relies on existing national data
  • No quantitative analysis provided
  • Focuses on implementation gaps rather than new solutions

Elsewhere in the Bofanglutide corpus

DBridging Biosynthesis and Bioavailability: Integrated Strategies for Tailoring Soybean Isoflavone Profiles.Comprehensive reviews in food science and food safety · 2026reviewDSpatiotemporal dynamics of the host-tumor metabolic interface: Implications for precision nutritional oncology.Genes & diseases · 2026reviewCA Ready-to-Use Recombinant Yeast Two-Hybrid Assay for Thyroxine Detection.Biosensors · 2026 · EC50 values ranged from 350 nM to 550 nM for thyroxine.In vitroCFe(III)-(II) Mineral Transformation and Associated Organic Matter Stabilization Processes in a Tidal Marsh Soil.Environmental science & technology · 2026 · Not reported in abstract.In vitroBGlobal, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.The lancet. HIV · 2026 · 2.06 million new HIV infections globally in 2023 (1.88-2.29 million).reviewAAssessing the Prognostic Value of Serial Seattle Angina Questionnaire Scores in Chronic Coronary Disease.Circulation. Population health and outcomes · 2023 · n=3405 · Each 5-point increase in the current SAQ-SS was associated with a 7% lower risk of the primary endpoint (hazard ratio, 0.93 [95% CI, 0.90-0.96]).Human